Literature DB >> 9643522

Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy.

M O Sator1, J Akramian, E A Joura, A Nessmann, A Wedrich, D Gruber, M Metka, J C Huber.   

Abstract

OBJECTIVES: To show the reducing effect of estrogens and progestins on the elevated intraocular pressure (IOP) in the case of a 56-year-old woman showing typical climacteric complaints, who was admitted to the menopause outpatient unit. She also suffered from a primary open-angle glaucoma treated with betaophtiole eye drops with intraocular pressures of 16-20 mmHg under this local therapy.
METHODS: IOP patterns were monitored by means of standardised daily pressure profiles four times a day before as well as 4 and 12 weeks after the beginning of hormone replacement therapy (HRT). The local glaucoma therapy remained unchanged.
RESULTS: During HRT, IOP levels were reduced from 16-20 mmHg before therapy to 12-15 mmHg at week 4 and to 13-15 mmHg at week 12 after the beginning of HRT.
CONCLUSION: The finding of a close chronological relationship between the onset of menopause and the development of a glaucoma is a potentially new indication for HRT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643522     DOI: 10.1016/s0378-5122(97)00091-1

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  17 in total

1.  Postmenopausal intraocular pressure changes in South Indian females.

Authors:  Sheila R Pai; Jnaneshwara P Shenoy; Shivakumar J; Sharad B Kole
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 2.  Eye diseases in women.

Authors:  Sakumi Kazama; Junichiro James Kazama; Noburo Ando
Journal:  Fukushima J Med Sci       Date:  2019-06-11

Review 3.  Estrogen deficiency accelerates aging of the optic nerve.

Authors:  Thasarat S Vajaranant; Louis R Pasquale
Journal:  Menopause       Date:  2012-08       Impact factor: 2.953

Review 4.  Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma.

Authors:  Kyrylo Fotesko; Bo Schneider Vohra Thomsen; Miriam Kolko; Rupali Vohra
Journal:  Cell Mol Neurobiol       Date:  2020-10-11       Impact factor: 5.046

Review 5.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

6.  Expression of estrogen receptor alpha and 17beta-hydroxysteroid dehydrogenase 4 in the ciliary body.

Authors:  Kaori Kobayashi; Ryo Iwakiri; Hiroshi Kobayashi; Satoshi Okinami
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-21       Impact factor: 3.117

7.  Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States.

Authors:  Ye Elaine Wang; Caitlin Kakigi; Diego Barbosa; Travis Porco; Rebecca Chen; Sophia Wang; Yingjie Li; Kuldev Singh; Louis R Pasquale; Shan C Lin
Journal:  Ophthalmology       Date:  2016-02-11       Impact factor: 12.079

8.  Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study.

Authors:  Thasarat S Vajaranant; Pauline M Maki; Louis R Pasquale; Anne Lee; Hajwa Kim; Mary N Haan
Journal:  Am J Ophthalmol       Date:  2016-03-03       Impact factor: 5.258

9.  Risk of glaucoma after early bilateral oophorectomy.

Authors:  Thasarat S Vajaranant; Brandon R Grossardt; Pauline M Maki; Louis R Pasquale; Arthur J Sit; Lynne T Shuster; Walter A Rocca
Journal:  Menopause       Date:  2014-04       Impact factor: 2.953

10.  Racial Differences in the Effects of Hormone Therapy on Incident Open-Angle Glaucoma in a Randomized Trial.

Authors:  Thasarat Sutabutr Vajaranant; Roberta M Ray; Louis R Pasquale; Julie A Mares; Robert Ritch; Emily W Gower; Mary N Haan; Rebecca D Jackson; Pauline M Maki
Journal:  Am J Ophthalmol       Date:  2018-08-04       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.